Browse News
Filter News
Found 28 articles
-
Philips Respironics reaches agreement with US government on a consent decree creating a clear path forward
4/10/2024
Following the FDA’s inspection of Philips Respironics’ facility in Murrysville in 2021 and the subsequent inspectional observations, the US Department of Justice, representing the US Food and Drug Administration, began discussions with Royal Philips in July 2022 regarding the terms of a proposed consent decree.
-
Philips provides update on completed set of test results for CPAP/BiPAP sleep therapy devices
5/16/2023
Royal Philips, provides an update on the comprehensive test and research program of its subsidiary Philips Respironics to assess potential health risks related to the polyester-based polyurethane sound abatement foam in specific sleep therapy and ventilator devices under the voluntary June 2021 recall notification/field safety notice.*
-
Philips sees some improvement in Q4 2022 and takes firm actions to address operational challenges in an uncertain environment
1/30/2023
2022 has been a very difficult year for Philips and our stakeholders, and we are taking firm actions to improve our execution and step up performance with urgency.
-
Philips provides update on completed set of test results for first-generation DreamStation sleep therapy devices
12/21/2022
Royal Philips provides an update on the comprehensive test and research program of its subsidiary Philips Respironics, following the voluntary recall notification/field safety notice* to address potential health risks related to the polyester-based polyurethane sound abatement foam in specific CPAP, BiPAP and mechanical ventilator devices.
-
Viemed Healthcare Announces Third Quarter 2022 Financial Results
11/1/2022
Viemed Healthcare, Inc. announced that it has reported its financial results for the three and nine months ended September 30, 2022.
-
Philips announces CEO succession
8/16/2022
Amsterdam, the Netherlands - Royal Philips, a global leader in health technology, announced that Roy Jakobs is proposed to succeed Frans van Houten as President and Chief Executive Officer, effective October 15, 2022.
-
Viemed Healthcare Announces Second Quarter 2022 Financial Results
8/2/2022
Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX:VMD.TO), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three and six months ended June 30, 2022.
-
Philips provides update on Philips Respironics’ PE-PUR sound abatement foam test and research program
6/28/2022
On June 14, 2021, RoyalPhilips’ subsidiary Philips Respironics, initiated a voluntary recall notification/field safety notice* to address potential health risks related to the polyester-based polyurethane sound abatement foam in specific CPAP, BiPAP and mechanical ventilator devices.
-
Philips Respironics issues voluntary recall notification/field safety notice* for the V60 ventilator product family
4/22/2022
Royal Philips, a global leader in health technology, announced that its subsidiary Philips Respironics is notifying customers of its V60/V60 Plus and V680 ventilators about a potential issue with the electrical circuit in these ventilators that controls the 35V power supply to the ventilator and alarm.
-
Philips Respironics provides update for the US on ongoing CPAP, BiPAP and Mechanical Ventilator field action
3/11/2022
Royal Philips’ subsidiary, Philips Respironics, provided an update on the remediation status in the US of the ongoing recall of certain sleep and respiratory care products in connection with identified potential health risks related to the polyester-based polyurethane sound abatement foam in these devices.
-
Viemed Healthcare Announces 2021 Financial Results
3/7/2022
Viemed Healthcare, Inc., a home medical equipment supplier and the nation’s largest independent provider of ventilation that provides post-acute respiratory care services, reported its financial results for the three months and year ended December 31, 2021.
-
Philips provides update on its financial performance in Q4 2021
1/12/2022
Royal Philips, a global leader in health technology, provided an update on the fourth-quarter 2021 and full-year 2021 financial results.
-
Philips provides update on the test and research program in connection with the CPAP, BiPAP and Mechanical Ventilator recall notification*
12/23/2021
On June 14, 2021, Royal Philips’ subsidiary, Philips Respironics, initiated a voluntary recall notification* for certain sleep and respiratory care products to address potential health risks related to the polyester-based polyurethane sound abatement foam in these devices.
-
Viemed Healthcare Announces Second Published Non-Invasive Ventilation Study
9/16/2021
Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX: VMD.TO), a home medical equipment supplier and the nation’s largest independent provider of ventilation that provides post-acute respiratory care services, announced another published non-invasive ventilation study led by Dr. William Frazier, Viemed’s Chief Medical Officer.
-
Philips starts repair and replacement program of first-generation DreamStation devices in the US in relation to earlier announced recall notification*
9/1/2021
Royal Philips announced an update in connection with the June 14, 2021 recall notification* for specific Philips sleep and respiratory care devices that was issued to address potential health risks related to the polyester-based polyurethane sound abatement foam component in these devices.
-
Viemed Healthcare Announces Second Quarter 2021 Financial Results
8/2/2021
Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD and TSX: VMD.TO), a home medical equipment supplier and the nation’s largest independent provider of ventilation that provides post-acute respiratory care services, announced today that it has reported its financial results for the three and six months ended June 30, 2021.
-
Pfizer has voluntarily recalled two lots of Chantix 0.5 mg tablets, two lots of Chantix 1 mg tablets, and eight lots of a Chantix kit consisting of 0.5mg/1 mg tablets.
-
Philips issues recall notification* to mitigate potential health risks related to the sound abatement foam component in certain sleep and respiratory care devices
6/14/2021
Following the company update on April 26, 2021, Royal Philips provides an update on the recall notification* for specific Philips Bi-Level Positive Airway Pressure, Continuous Positive Airway Pressure, and mechanical ventilator devices to address identified potential health risks related to the polyester-based polyurethane sound abatement foam component in these devices.
-
Xtant Medical Announces Results of Special Meeting of Stockholders
2/14/2018
As a result of the approval of all proposals at the Special Meeting, Xtant expects that it will be able to fully execute its previously announced restructuring plan.
-
Royal Philips Electronics N.V.'s Spectranetics Recalls Bridge Occlusion Balloon
8/31/2017